Effects of type II alveolar epithelial cells on T cell mitogenic responses to concanavalin A and purified protein derivatives

Microbiology and Immunology

Volumn 49, Issue 10, 2005, Pages 885-890

  Sato, Katsumasa ^a   Shimizu, Toshiaki ^a   Sano, Chiaki ^a   Tomioka, Haruaki ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

A 549 cells; Mycobacterium tuberculosis; PBMCs; Type II alveolar epithelial cells

Indexed keywords

CONCANAVALIN A; SUPPRESSOR FACTOR; TUBERCULIN;

ARTICLE; CELL CONTACT; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS CELL TYPE 2; MITOGENESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 27544474664     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03679.x     Document Type: Article

References (14)

1. Akira, S., Taga, T., and Kishimoto, T. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78.
2. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery 95: 71-77.
3. Bermudez, L.E., and Goodman, J. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar epithelial cells. Infect. Immun. 64: 1400-1406.
4. Bermudez, L.E., Sangari, F.J., Kolonoski, P., Petrofsky, M., and Goodman, J. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun. 70: 140-146.
5. Boron, P.J., Crouch, E.C., Lewis, J.F., Wright, J.R., Possmayer, F., and Fraher, L.J. 1998. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J. Immunol. 161: 4599-4603.
6. Castro-Garza, J., King, C.H., Swords, W.E., and Quinn, F.D. 2002. Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers. FEMS Microbiol. Lett. 212: 145-149.
7. Honda, Y., Takahashi, H., Kuroki, Y., Akino, T., and Abe, S. 1996. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 109: 1006-1009.
8. Lin, Y., Zhang, M., and Barnes, P.F. 1998. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66: 1121-1126.
9. Maw, W.W., Shimizu, T., Sato, K., and Tomioka, H. 1997. Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T cell proliferation. Clin. Exp. Immunol. 108: 26-33.
10. Mehta, P.K., King, C.H., White, E.M., Murtagh, J.J., and Quinn, F.D. 1996. Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect. Immun. 64: 2673-2679.
11. Ogasawara, K., Tomioka, H., Shimizu, T., Sano, C., Kawauchi, H., and Sato, K. 2002. Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission. Clin. Exp. Immunol. 129: 272-280.
12. Sato, K., Tomioka, H., Shimizu, T., Gonda, T., Ota, F., and Sano, C. 2002. Type II alveolar cells play roles in macrophage-rnediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J. Infect. Dis. 185: 1139-1147.
13. Selam, B., Kayisli, U.A., Garcia-Velasco, J.A., Akbas, G.E., and Arici, A. 2002. Regulation of Fas ligand expression by IL-8 in human endometrium. J. Clin. Endocrinol. Metab. 87: 3921-3927.
14. Tomioka, H. 2003. Type II pneumocytes in the evaluation of drug antimycobacterial activity. Expert. Opin. Pharmacother. 4: 127-139.